Trial intelligence / Profile preview

Fospropofol vs Propofol for Deep Sedation in ICU

NCT05870514Phase 2Unknown

Start
Jun 2023
Primary completion
Mar 2024
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fospropofol disodium in critical illness. Status: unknown.

02

Drugs

fospropofol disodium
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT05870514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05870514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call